EMD Millipore Opens Biopharmaceutical Technical Center in Shanghai

The facility will provide support, training and validation services to EMD Millipore’s biopharma customers with operations in China.

EMD Millipore, the Life Science division of Merck KGaA, yesterday opened its Biopharmaceutical Technical and Training Center in Shanghai, China. The 28,000-sq.-ft. facility will provide support, training and validation services to EMD Millipore’s biopharma customers with operations in China.

"We are responding to China’s commitment to strengthen regulatory requirements designed to ensure drug safety,” said Jean-Paul Mangeolle, head of EMD Millipore’s Process Solutions business. “Our new Biopharmaceutical Technical Center is unique in that we can support and even train our pharmaceutical customers to meet the new Chinese and global regulations. Today we have taken a significant step not only expanding our 30 years of local offerings in China, but also to support the effort to produce safe, quality drugs in this important and fast growing region.”